Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Loos

Showing results (141-150 of 288) with videos related to

Pageof 29
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Macrophage C1q: characterization of a membrane form of C1q and of multimers of C1q subunitsH Martin, H P Heinz, K Reske, et al.
Deutsche Medizinische Wochenschrift (1946)|March 27, 1987
[Formation of IgG antibodies to C1 inhibitor as the cause of life-threatening angioedema]K Bork, J Alsenz, M Böckers, et al.
Immunology|March 1, 1996
The collagen-like component of the complement system, C1q, is recognized by 7 S autoantibodies and is functionally impaired in synovial fluids of patients with rheumatoid arthritisP K Trinder, M J Maeurer, D Brackertz, et al.
Psychological Reports|December 1, 1992
Stress profiles for mothers and fathers of children with autismD Moes, R L Koegel, L Schreibman, et al.
Behring Institute Mitteilungen|December 1, 1993
C1q in autoimmune diseases: rheumatoid arthritisM J Maeurer, P K Trinder, S Störkel, et al.
Genes, Brain, and Behavior|August 10, 2017
Constitutive loss and acute pharmacological manipulation of ErbB4 signaling do not affect attention and inhibitory control in miceE Marchisella, R Wijnands, B Koopmans, et al.
Immunopharmacology|February 26, 1998
Molecular basis of a new type of C1q-deficiency associated with a non-functional low molecular weight (LMW) C1q: parallels and differences to other known genetic C1q-defectsF Petry, G Hauptmann, J Goetz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1980
Differentiation of hemolytically active fluid-phase and cell-bound human C1q by an ant venom-derived polysaccharideD R Schultz, M Loos, F Bub, et al.
Arzneimittel-Forschung|January 1, 1985
Antimicrobial activity of clavinesE Eich, D Eichberg, G Schwarz, et al.
Physical Review Letters|May 27, 2023
Long-Range Order and Directional Defect Propagation in the Nonreciprocal XY Model with Vision Cone InteractionsSarah A M Loos, Sabine H L Klapp, Thomas Martynec
Pageof 29

Showing results (141-150 of 288) with videos related to

Sort By:
Pageof 29
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Macrophage C1q: characterization of a membrane form of C1q and of multimers of C1q subunitsH Martin, H P Heinz, K Reske, et al.
Deutsche Medizinische Wochenschrift (1946)|March 27, 1987
[Formation of IgG antibodies to C1 inhibitor as the cause of life-threatening angioedema]K Bork, J Alsenz, M Böckers, et al.
Immunology|March 1, 1996
The collagen-like component of the complement system, C1q, is recognized by 7 S autoantibodies and is functionally impaired in synovial fluids of patients with rheumatoid arthritisP K Trinder, M J Maeurer, D Brackertz, et al.
Psychological Reports|December 1, 1992
Stress profiles for mothers and fathers of children with autismD Moes, R L Koegel, L Schreibman, et al.
Behring Institute Mitteilungen|December 1, 1993
C1q in autoimmune diseases: rheumatoid arthritisM J Maeurer, P K Trinder, S Störkel, et al.
Genes, Brain, and Behavior|August 10, 2017
Constitutive loss and acute pharmacological manipulation of ErbB4 signaling do not affect attention and inhibitory control in miceE Marchisella, R Wijnands, B Koopmans, et al.
Immunopharmacology|February 26, 1998
Molecular basis of a new type of C1q-deficiency associated with a non-functional low molecular weight (LMW) C1q: parallels and differences to other known genetic C1q-defectsF Petry, G Hauptmann, J Goetz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1980
Differentiation of hemolytically active fluid-phase and cell-bound human C1q by an ant venom-derived polysaccharideD R Schultz, M Loos, F Bub, et al.
Arzneimittel-Forschung|January 1, 1985
Antimicrobial activity of clavinesE Eich, D Eichberg, G Schwarz, et al.
Physical Review Letters|May 27, 2023
Long-Range Order and Directional Defect Propagation in the Nonreciprocal XY Model with Vision Cone InteractionsSarah A M Loos, Sabine H L Klapp, Thomas Martynec
Pageof 29